Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist/3rd communication: Hemodynamic effects of valsartan in rats and dogs

Arzneimittel-Forschung/Drug Research

Volumn 47, Issue 5, 1997, Pages 620-625

  Hayashi, Naoyuki ^a   Yamamoto, Shigeru ^a   Kometani, Motohiko ^a   Nakao, Kenzo ^a  

^a CIBA GEIGY LTD   (Switzerland)

Author keywords

Angiotensin II receptor antagonists; CAS 137862 53 4; CGP 48933, systemic and renal hemodynamics; Enalapril; Valsartan

Indexed keywords

ANGIOTENSIN 1 RECEPTOR ANTAGONIST; VALSARTAN;

ANIMAL MODEL; ANTIHYPERTENSIVE THERAPY; ARTICLE; DOG; DRUG EFFECT; HEMODYNAMIC MONITORING; HYPERTENSION; NONHUMAN; ORAL DRUG ADMINISTRATION; RAT; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; ANTIHYPERTENSIVE AGENTS; BLOOD CIRCULATION; BLOOD PRESSURE; BRADYKININ; CARDIAC OUTPUT; DOGS; ENALAPRIL; FEMALE; HEART RATE; HEMODYNAMIC PROCESSES; MALE; RATS; RATS, INBRED SHR; RATS, WISTAR; RECEPTOR, ANGIOTENSIN, TYPE 1; RECEPTOR, ANGIOTENSIN, TYPE 2; RECEPTORS, ANGIOTENSIN; RENAL CIRCULATION; TETRAZOLES; VALINE; VASCULAR RESISTANCE;

EID: 0030995343     PISSN: 00044172     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Criscione, L., de Gasparo, M., Buehlmayer, P., Br. J. Pharmacol. 110, 761 (1993)
2. Yamamoto, S., Hayashi, N., Kometani, M. et al., Arzneim.-Forsch./Drug Res. 47(I), 604 (1997)
3. Kometani, M., Hayashi, N., Yamamoto, S. et al., Arzneim.-Forsch./Drug Res. 47 (I), 613 (1997)
4. Baker, K. M., Booz, G. W., Dostal, D. E., Annu. Rev. Physiol. 54, 227 (1992)
5. Chan, D. P., Sandok, E. K., Aarhus, L. L., Am. J. Hypertens. 5, 354 (1992)
6. Schoelkens, B. A., Becker, R. H. A., Kaiser, J., Arzneim.-Forsch./Drug Res. 34 (II), 1417 (1984)
7. Noguchi, K., Kato, T., Sunagawa, R., Japan. J. Pharmacol. 40, 373 (1986)
8. Yuan, B. H., Robinette, J. B., Conger, J. D., Am. J. Physiol. 258, F741 (1990)
9. Denton, K. M., Fennessy, P. A., Alcorn, D., Am. J. Physiol. 262, F367 (1992)
10. Navar, L. G., Saccomani, G., Mitchell, K. D., Am. J. Hypertens. 4, 90 (1991)
11. Hall, J. F., Am. J. Physiol. 250, R960 (1986)
12. Cogan, M. G., Hypertens. 15, 451 (1990)
13. Quinn, S. J., Annu. Rev. Physiol. 50, 409 (1988)
14. Bovee, K. C., Wong, P. C., Timmermans, P. B. M. W. M., Am. J. Hypertens. 4, 327S (1991)
15. Chan, D. P., Sandok, E. K., Aarhus, L. L., Am. J. Hypertens. 5, 354 (1992)
16. Clark, K. L., Robertson, M. J., Drew, G. M., Br. J. Pharmacol. 104, 78P (1991)
17. Clark, K. L., Robertson, M. J., Drew, G. M., Br. J. Pharmacol. 109, 148 (1993)
18. Ito, K., Shiomi, M., Kito, G., Hypertens. Res. 18, 69 (1995)
19. Keiser, J. A., Bjork, F. A., Hodges, J. C., J. Pharmacol. Ther. 262, 1154 (1992)
20. Kivlighn, S. D., Gabel, R. A., Siegl, P. K. S., FASEB J. 6, A982 (1992)
21. Majid, D. S. A., Williams, A., Navar, L. G., FASEB J. 6, A1511 (1992)
22. Wong, P. C., Hart, S. D., Dunica, J. V., Eur. J. Pharmacol. 202, 323 (1991)
23. Hakkinen, J. P., Miller, M. W., Smith, A. H., Cardiovasc. Res. 29, 74 (1995)
24. Brooks, D. P., Fredrickson, T. A., Weinstock, J., Arch. Pharmacol. 345, 673 (1992)
25. Rasmussen-Ortega, K., Printz, M. P., FASEB J. 5, A869 (1991)
26. Smith, R. D., Chiu, A. T., Wong, P. C., Annu. Rev. Pharmacol. Toxicol. 32, 135 (1992)
27. Timmermans, P. B. M. W. M., Wong, P. C., Chiu, A. T., Pharmacol. Rev. 45, 205 (1993)
28. Harris, D. N., Heran, C. L., Goldenberg, H. J., Eur. J. Pharmacol. 51, 345 (1978)
29. Ishibashi, T., Tatebe, S., Mitomi, A., Cardiovasc. Drugs Ther. 5, 635 (1991)
30. Gavras, H., Benetos, A., Gavras, I., Hypertension 9, III-147 (1987)
31. Keeton, T. K., Campbell, W. B., Pharmacol. Rev. 31, 81 (1981)